About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
University of Miami's 2nd Biennial Miami Leukemia Symposium
AML Biology and Treatment
MDS Biology and Treatment
ALL Biology and Treatment
CLL Therapy in 2019
CML and MPNs: Final Frontiers and New Breakthroughs
Myeloid Biology and Novel Therapies
Event
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
2020 Update on Atypical CML, CMML & CNL: Is There Clinical Benefit to Ruxolitinib for Patients With CSF3R Mutation?
By
University of Miami's 2nd Biennial Miami Leukemia Symposium
FEATURING
Jeffrey Tyner
By
University of Miami's 2nd Biennial Miami Leukemia Symposium
FEATURING
Jeffrey Tyner
30 views
October 27, 2020
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
CML and MPNs: Final Frontiers and New Breakthroughs
21:24
University of Miami's 2nd Biennial Miami Leukemia Symposium
2020 Update on Atypical CML, CMML & CNL: Is There Clinical Benef…
Feat.
J. Tyner
26:24
University of Miami's 2nd Biennial Miami Leukemia Symposium
2020 Update on CML: What Strategies Can Help Overcome Multi-TKI Resi…
Feat.
J. Cortés
25:18
University of Miami's 2nd Biennial Miami Leukemia Symposium
2020 Update on Ph- MPN: What Are the Potential Benefits and Limitati…
Feat.
O. Odenike
21:19
University of Miami's 2nd Biennial Miami Leukemia Symposium
2020 Update on BPDCN: Efficacy Analysis of Available Standard Therap…
Feat.
N. Pemmaraju
